These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

764 related articles for article (PubMed ID: 6439269)

  • 1. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
    Fouque F; Vargaftig BB
    Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation and inhibition by clonidine of PAF-acether-induced human platelet activation.
    Fouque F; Vargaftig BB
    Eur J Pharmacol; 1987 Mar; 135(2):211-8. PubMed ID: 3582495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenaline and PAF-acether synergize to trigger cyclooxygenase-independent activation of plasma-free human platelets.
    Vargaftig BB; Fouque F; Benveniste J; Odiot J
    Thromb Res; 1982 Nov; 28(4):557-73. PubMed ID: 7164036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium.
    Cattaneo M; Canciani MT; Mannucci PM
    Thromb Haemost; 1985 Apr; 53(2):221-4. PubMed ID: 3927505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor (PAF-acether): thromboxane-independent synergism with adrenaline on human platelets and recent insights into its mode of action.
    Fouque F; Joseph D; Vargaftig BB
    Agents Actions; 1982 Dec; 12(5-6):720-2. PubMed ID: 7164947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets.
    Adnot S; Joseph D; Vargaftig BB
    Agents Actions; 1987 Jun; 21(1-2):195-202. PubMed ID: 3115070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances.
    Vargaftig BB; Joseph D; Marlas G; Chevance LG
    Thromb Haemost; 1982 Aug; 48(1):67-71. PubMed ID: 7135345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperative effects of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) and exogenous arachidonic acid in stimulation of human blood platelets.
    Ostermann G; Till U; Thielmann K
    Thromb Res; 1984 Feb; 33(4):409-18. PubMed ID: 6710440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenaline/PAF acether synergism on human platelets: involvement of Hydergine.
    Fouque F; Vargaftig BB
    J Pharmacol; 1985; 16 Suppl 3():129-34. PubMed ID: 4094442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic actions of PAF-acether and sodium arachidonate in human platelet aggregation. 1. Studies in normal human platelet rich plasma.
    Altman R; Scazziota A; Rouvier J; Cacchione R
    Thromb Res; 1986 Jul; 43(1):103-11. PubMed ID: 3014677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation between inhibition of phospholipid methylation and production of PAF-acether by rabbit platelets.
    Touqui L; Chignard M; Jacquemin C; Wal F; Vargaftig BB
    Experientia; 1984 Apr; 40(4):374-7. PubMed ID: 6714369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAF-acether may not mediate the third pathway of platelet aggregation since self-desensitization reduces the effects of low thrombin but enhances those of convulxin.
    Wal F; Joseph D; Touqui L; Vargaftig BB
    Thromb Haemost; 1985 Feb; 53(1):99-104. PubMed ID: 3992525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
    Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
    Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene.
    Lefort J; Rotilio D; Vargaftig BB
    Br J Pharmacol; 1984 Jul; 82(3):565-75. PubMed ID: 6430375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation.
    Lanza F; Cazenave JP; Beretz A; Sutter-Bay A; Kretz JG; Kieny R
    Agents Actions; 1986 Aug; 18(5-6):586-95. PubMed ID: 3020942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic actions of paf-acether and sodium arachidonate in human platelet aggregation. 2. Unexpected results after aspirin intake.
    Altman R; Scazziota A
    Thromb Res; 1986 Jul; 43(1):113-20. PubMed ID: 3088757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-O-alkyl-2-acyl-sn-glycero-3-phosphorylcholine is the precursor of platelet-activating factor in stimulated rabbit platelets. Evidence for an alkylacetyl-glycerophosphorylcholine cycle.
    Touqui L; Jacquemin C; Dumarey C; Vargaftig BB
    Biochim Biophys Acta; 1985 Jan; 833(1):111-8. PubMed ID: 3967037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of adrenaline-induced human platelet aggregation by the structurally related Paf antagonist Ro 19-3704.
    Schattner M; Parini A; Fouque F; Vargaftig BB; Touqui L
    Br J Pharmacol; 1989 Apr; 96(4):759-66. PubMed ID: 2787179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of ADP to the amplification of primary platelet aggregation by platelet activating factor (PAF): modulatory role of aspirin.
    Lauri D; Cerletti C; de Gaetano G
    Agents Actions; 1986 Mar; 17(5-6):506-11. PubMed ID: 3706054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988.
    Nunez D; Chignard M; Korth R; Le Couedic JP; Norel X; Spinnewyn B; Braquet P; Benveniste J
    Eur J Pharmacol; 1986 Apr; 123(2):197-205. PubMed ID: 3086108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.